Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Toyka

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1994
Clinical implementation of anti-acetylcholine receptor antibodiesK Toyka
Immunology Today|October 8, 2014
Humoral or cellular effector mechanisms?H Kolb, K Toyka
Der Internist|March 23, 1999
[Successful treatment of multiple sclerosis with beta-interferon]P Rieckmann, R Gold, K Toyka
The Cochrane Database of Systematic Reviews|April 21, 2006
Intravenous immunoglobulin for myasthenia gravisP Gajdos, S Chevret, K Toyka
The Cochrane Database of Systematic Reviews|February 7, 2008
Intravenous immunoglobulin for myasthenia gravisP Gajdos, S Chevret, K Toyka
The Cochrane Database of Systematic Reviews|January 10, 2003
Plasma exchange for myasthenia gravisP Gajdos, S Chevret, K Toyka
The Cochrane Database of Systematic Reviews|June 14, 2003
Intravenous immunoglobulin for myasthenia gravisP Gajdos, S Chevret, K Toyka
European Journal of Immunology|May 1, 1995
Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2S Jung, K Toyka, H P Hartung
Brain : a Journal of Neurology|August 1, 1996
T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodiesS Jung, K Toyka, H P Hartung
Journal of Neurology|May 1, 1994
Atraumatic needle reduces the incidence of post-lumbar puncture syndromeB Müller, K Adelt, H Reichmann, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1994
Clinical implementation of anti-acetylcholine receptor antibodiesK Toyka
Immunology Today|October 8, 2014
Humoral or cellular effector mechanisms?H Kolb, K Toyka
Der Internist|March 23, 1999
[Successful treatment of multiple sclerosis with beta-interferon]P Rieckmann, R Gold, K Toyka
The Cochrane Database of Systematic Reviews|April 21, 2006
Intravenous immunoglobulin for myasthenia gravisP Gajdos, S Chevret, K Toyka
The Cochrane Database of Systematic Reviews|February 7, 2008
Intravenous immunoglobulin for myasthenia gravisP Gajdos, S Chevret, K Toyka
The Cochrane Database of Systematic Reviews|January 10, 2003
Plasma exchange for myasthenia gravisP Gajdos, S Chevret, K Toyka
The Cochrane Database of Systematic Reviews|June 14, 2003
Intravenous immunoglobulin for myasthenia gravisP Gajdos, S Chevret, K Toyka
European Journal of Immunology|May 1, 1995
Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2S Jung, K Toyka, H P Hartung
Brain : a Journal of Neurology|August 1, 1996
T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodiesS Jung, K Toyka, H P Hartung
Journal of Neurology|May 1, 1994
Atraumatic needle reduces the incidence of post-lumbar puncture syndromeB Müller, K Adelt, H Reichmann, et al.
Pageof 4